Reshma Kewalramani, CEO & President: Vertex Pharmaceuticals VRTX Planned sale · Filed 02/27

Trade details

Type: Planned sale notice
Stock: Vertex Pharmaceuticals VRTX
Person: Reshma KewalramaniCEO & President
Planned sale date: 26/02/27
Filed: 26/02/27

$19.7M to be sold

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/28~03/29

Reshma Kewalramani's recent trades

Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.7M
15,580 sh
$7.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3M
5,995 sh
$3M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.7M
3,498 sh
$1.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,278 sh
$1.6M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,725 sh
$1.3M
Filed 03/03
Traded 02/27

Reshma Kewalramani, CEO — plans to sell 40,000 sh of Vertex Pharmaceuticals VRTX · $19.7M · around 02/27 · 10b5-1 plan | Whalegun